Trial Profile
A Phase II, Randomised, Double-blind, Vehicle-controlled, Cross-over Study to Determine the Anti-pruritic Efficacy, Safety and Local Dermal Toleration of SRD174 Cream in Subjects With Atopic Dermatitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2014
Price :
$35
*
At a glance
- Drugs SRD 174 (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors Serentis
- 09 May 2014 New trial record